Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition

NCT00968097 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class

Stopped Early Phase I study of \[123I\]MNI-340 did not evidence as marker of disease

Conditions

Interventions

Sponsor

Institute for Neurodegenerative Disorders